Interventional Cardiology Devices | Medtech 360 | Market Analysis | US | 2017
Upcoming changes to the US health care policy and reimbursement landscape proposed by CMS, along with new product launches (including the highly anticipated BVS), greater patient selection scrutiny, and slipping ASPs, will continue to place downward pressure on the large, yet contracting, US IC market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the US, with market projections across a 10-year period.